These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 36191625

  • 1. Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction.
    Luo F, Zhao J, Liu S, Xue Y, Tang D, Yang J, Mei Y, Li G, Xie Y.
    Biochem Pharmacol; 2022 Nov; 205():115278. PubMed ID: 36191625
    [Abstract] [Full Text] [Related]

  • 2. Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer.
    Yang T, Xiao Y, Liu S, Luo F, Tang D, Yu Y, Xie Y.
    Phytomedicine; 2023 Jun; 114():154780. PubMed ID: 37004402
    [Abstract] [Full Text] [Related]

  • 3. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L, Cheng G, Liu S, Pi Z, Liu Z, Song F.
    J Pharm Biomed Anal; 2019 Feb 20; 165():268-275. PubMed ID: 30572191
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer.
    Zong L, Cheng G, Zhao J, Zhuang X, Zheng Z, Liu Z, Song F.
    Molecules; 2022 Feb 14; 27(4):. PubMed ID: 35209071
    [Abstract] [Full Text] [Related]

  • 5. Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance.
    Luo F, Yang J, Yang X, Mi J, Ye T, Li G, Xie Y.
    Phytomedicine; 2024 Oct 14; 133():155945. PubMed ID: 39146878
    [Abstract] [Full Text] [Related]

  • 6. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner.
    Zhong ZF, Tan W, Qiang WW, Scofield VL, Tian K, Wang CM, Qiang WA, Wang YT.
    Mol Biosyst; 2016 Apr 26; 12(5):1626-37. PubMed ID: 26987443
    [Abstract] [Full Text] [Related]

  • 7. Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells.
    Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, Deregowska A, Wnuk M.
    Apoptosis; 2017 Jun 26; 22(6):800-815. PubMed ID: 28213701
    [Abstract] [Full Text] [Related]

  • 8. Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin.
    Chen Q, Meng YQ, Xu XF, Gu J.
    Anticancer Drugs; 2017 Sep 26; 28(8):880-887. PubMed ID: 28609310
    [Abstract] [Full Text] [Related]

  • 9. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.
    Aldonza MB, Hong JY, Bae SY, Song J, Kim WK, Oh J, Shin Y, Lee SH, Lee SK.
    PLoS One; 2015 Sep 26; 10(6):e0127841. PubMed ID: 26098947
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M, Park JH.
    PLoS One; 2015 Sep 26; 10(7):e0132285. PubMed ID: 26158266
    [Abstract] [Full Text] [Related]

  • 11. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C, Caffarra C, La Monica S, Galetti M, Alfieri RR, Cavazzoni A, Galvani E, Generali D, Petronini PG, Bonelli MA.
    Breast Cancer Res Treat; 2013 Aug 26; 141(1):67-78. PubMed ID: 23963659
    [Abstract] [Full Text] [Related]

  • 12. Hyaluronic acid/dextran-based polymeric micelles co-delivering ursolic acid and doxorubicin to mitochondria for potentiating chemotherapy in MDR cancer.
    Guo Y, Yang X, Zhang Y, Luo F, Yang J, Zhang X, Mi J, Xie Y.
    Carbohydr Polym; 2024 May 15; 332():121897. PubMed ID: 38431408
    [Abstract] [Full Text] [Related]

  • 13. Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis.
    Lu Q, Chen W, Ji Y, Liu Y, Xue X.
    Cancer Biother Radiopharm; 2022 Oct 15; 37(8):673-683. PubMed ID: 33493421
    [Abstract] [Full Text] [Related]

  • 14. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
    Xue C, Wang C, Sun Y, Meng Q, Liu Z, Huo X, Sun P, Sun H, Ma X, Ma X, Peng J, Liu K.
    Oncotarget; 2017 Jan 31; 8(5):8622-8632. PubMed ID: 28052008
    [Abstract] [Full Text] [Related]

  • 15. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.
    Wang Y, Zhu S, Liu H, Wei W, Tu Y, Chen C, Song J, Li J, Sun S, Wang C, Xu Z.
    Dis Markers; 2019 Jan 31; 2019():7420196. PubMed ID: 31929843
    [Abstract] [Full Text] [Related]

  • 16. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
    Dartier J, Lemaitre E, Chourpa I, Goupille C, Servais S, Chevalier S, Mahéo K, Dumas JF.
    Biochim Biophys Acta Gen Subj; 2017 May 31; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Hu D, Meng RY, Nguyen TV, Chai OH, Park BH, Lee JS, Kim SM.
    Mol Med Rep; 2023 Jan 31; 27(1):. PubMed ID: 36382656
    [Abstract] [Full Text] [Related]

  • 18. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, Chung HY, Kim HS.
    Biochim Biophys Acta; 2014 Jan 31; 1840(1):615-25. PubMed ID: 24161697
    [Abstract] [Full Text] [Related]

  • 19. Ursolic acid induces mitochondrial biogenesis through the activation of AMPK and PGC-1 in C2C12 myotubes: a possible mechanism underlying its beneficial effect on exercise endurance.
    Chen J, Wong HS, Leong PK, Leung HY, Chan WM, Ko KM.
    Food Funct; 2017 Jul 19; 8(7):2425-2436. PubMed ID: 28675237
    [Abstract] [Full Text] [Related]

  • 20. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway.
    Meng Y, Lin ZM, Ge N, Zhang DL, Huang J, Kong F.
    Am J Chin Med; 2015 Jul 19; 43(7):1471-86. PubMed ID: 26503559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.